Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...

The combination therapy failed to beat out the company’s other cancer therapy, Opdivo, in patients living with melanomas.

Yibin Kang, a professor in the Department of Molecular Biology, discussed new breast cancer research in his lab.

The BC Cancer Foundation has launched a $6.8 million fundraising campaign to expand provincial immunotherapy research program ...

London scientists find new way to predict which tumours will become aggressive - Discovery paves way for treatments to stop ...

A research team has developed a multi-medium approach (MMA) to identify reproducible volatile organic compounds (VOCs) in ...

The study from The Hebrew University of Jerusalem, led by Prof. Sheera Adar and her graduate student Elisheva Heilbrun-Katz ...

A combination of human pedigree analysis and fruit fly genetics has identified a gene variant that appears to prevent PIGA-CDG, a rare but serious seizure disorder. The findings could ultimately lead ...

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.

Opdualag is a fixed-dose combination of nivolumab, a programmed death receptor-1 blocking antibody, and relatlimab, a lymphocyte activation gene 3 blocking antibody.

Kailee Olson, the 34-year-old Duluth East girls basketball assistant coach and granddaughter of Bob McDonald, was recently ...